|
Reuters
Wednesday, 20 December 2006
|
|
 Reuters - CVS Corp. filed a registration
for its proposed acquisition of Caremark Rx Inc. on
Tuesday, a day after pharmacy benefits manager Express Scripts
Inc. swooped in with a higher offer.
|
|
Read more...
|
|
|
AP
Tuesday, 19 December 2006
|
|
AP - Danish biotech Genmab A/S on Tuesday signed a deal worth up to $2.1 billion with pharmaceutical company GlaxoSmithKline PLC for the global commercialization of a leukemia treatment. |
|
Read more...
|
|
|
USATODAY.com
Tuesday, 19 December 2006
|
|
USATODAY.com - Pharmacy benefits manager Express Scripts said Monday that it is offering to buy rival Caremark RX for about $26 billion, threatening to break up an offer made last month by drugstore chain CVS Corp. |
|
Read more...
|
|
|
AFP
Monday, 18 December 2006
|
|
 AFP - US healthcare company Express Scripts announced a 26-billion-dollar counteroffer for drug distributor Caremark Rx, besting a 21-billion-dollar bid by the CVS pharmacy chain.
|
|
Read more...
|
|
|
Reuters
Monday, 18 December 2006
|
|
 Reuters - U.S. pharmacy benefits manager Express
Scripts Inc. said on Monday it was offering to buy
rival Caremark RX for about $26 billion, threatening to
break up a deal struck last month with drugstore chain CVS
Corp. .
|
|
Read more...
|
|
|
AP
Monday, 18 December 2006
|
|
AP - Pharmacy-benefit manager Express Scripts Inc. launched a $26 billion bid Monday for its larger competitor Caremark Rx Inc., potentially scuttling a competing offer from drug chain CVS/pharmacy. |
|
Read more...
|
|
|
Reuters
Monday, 18 December 2006
|
|
 Reuters - Bowing to pressure from an Icos Corp.
shareholder, Eli Lilly and Co. said on Monday
it has increased its offer for the biotechnology company to
$2.3 billion from an earlier bid of $2.1 billion.
|
|
Read more...
|
|
|
Reuters
Monday, 18 December 2006
|
|
 Reuters - Drug company Eli Lilly has
encouraged primary care physicians to use Zyprexa, a powerful
drug for schizophrenia and bipolar disorder, in patients who
did not have either condition, the New York Times reported on
its Web site on Monday, citing internal Lilly marketing
materials.
|
|
Read more...
|
|
|
AP
Monday, 18 December 2006
|
|
AP - Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its Web site Sunday, citing internal documents from the drug maker and e-mail messages of its managers. |
|
Read more...
|
|
|
Reuters
Saturday, 16 December 2006
|
|
 Reuters - IBM said on Friday it has developed
technology to help drug distributors, manufacturers and
retailers prevent counterfeit drugs from making their way into
the market.
|
|
Read more...
|
|
|
Reuters
Friday, 15 December 2006
|
|
Reuters - The U.S. Food and Drug
Administration needs to more closely regulate
direct-to-consumer advertising of prescription drugs, the
Government Accountability Office said on Thursday. |
|
Read more...
|
|
|
|
<< Start < Previous 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 106 - 126 of 319 |
